• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2300031 奥木替韦单抗注射液 Ormutivimab Injection Biological Products Supplementary Application 2023-02-09 view
CYSB2300023 奥木替韦单抗注射液 Ormutivimab Injection Biological Products Supplementary Application 2023-01-31 view
CXSS2000039 重组人源抗狂犬病毒单抗注射液 Ormutivimab Injection Biological Products(1) New Drug Application 2020-07-04 华北制药金坦生物技术股份有限公司 NCPC Genetech BIOTECHNOLOGY Co Ltd In Review 2020-07-02 view
CXSS2000040 重组人源抗狂犬病毒单抗注射液 Ormutivimab Injection Biological Products(1) New Drug Application 2020-07-04 华北制药金坦生物技术股份有限公司,华北制药集团新药研究开发有限责任公司 Certificate Issued 2021-08-13 view
CYSB1800076 重组人源抗狂犬病毒单抗注射液 Ormutivimab Injection Biological Products Supplementary Application 2018-04-27 华北制药集团新药研究开发有限责任公司 North China Pharmaceutical Group New Drug R&D Co Ltd Certificate Issued 2018-07-13 view
CYSB1800075 重组人源抗狂犬病毒单抗注射液 Ormutivimab Injection Biological Products Supplementary Application 2018-04-27 华北制药集团新药研究开发有限责任公司 North China Pharmaceutical Group New Drug R&D Co Ltd Certificate Issued 2018-07-13 view
CXSL0700014 重组人源抗狂犬病毒单抗注射液 Ormutivimab Injection Biological Products(1) New Drug Application 2008-03-04 华北制药集团新药研究开发有限责任公司 North China Pharmaceutical Group New Drug R&D Co Ltd Certificate Issued 2009-07-09 view
CXSL0700013 重组人源抗狂犬病毒单抗注射液 Ormutivimab Injection Biological Products(1) New Drug Application 2007-11-11 华北制药集团新药研究开发有限责任公司 North China Pharmaceutical Group New Drug R&D Co Ltd Certificate Issued 2009-07-09 view